HNF4A and Sepsis: Our findings are expected to significantly impact both the HNF4α field, particularly its role in hepatic acute phase response, and the sepsis field, emphasizing HNF4α as a potential therapeutic target and the HNF4α agonist NCT as a new treatment option.